Abstract: This invention relates to compositions and methods or the detection of immunodeficiency virs infection, especially immunodeficiency virus-1 (HIV-1) infection. The invention particularly concerns compositions and methods that may be used in HIV vaccine recipients whose sera may contain vaccine-generated anti-HIV-1 antibodies.
Type:
Application
Filed:
December 23, 2010
Publication date:
August 18, 2011
Applicant:
The United States of America as Represented by the Secretary of Health and Human Services, NIH
Abstract: This invention relates to compositions and methods or the detection of immunodeficiency virus infection, especially immunodeficiency virus-1 (HIV-1) infection. The invention particularly concerns compositions and methods that may be used in HIV vaccine recipients whose sera may contain vaccine-generated anti-HIV-1 antibodies.
Type:
Application
Filed:
September 2, 2005
Publication date:
January 22, 2009
Applicant:
The United States of America as Represented by the Secretary of Health and Human Services, NIH